APA (7th ed.) Citation

Møller-Bisgaard, S., Ejbjerg, B., Eshed, I., Hørslev-Petersen, K., Hetland, M., Jurik, A., . . . Pedersen, J. (2017). Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: Results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA). Scandinavian Journal of Rheumatology, 46(5), 335. https://doi.org/10.1080/03009742.2016.1209550

Chicago Style (17th ed.) Citation

Møller-Bisgaard, S., et al. "Effect of a Treat-to-target Strategy Based on Methotrexate and Intra-articular Betamethasone with or Without Additional Cyclosporin on MRI-assessed Synovitis, Osteitis, Tenosynovitis, Bone Erosion, and Joint Space Narrowing in Early Rheumatoid Arthritis: Results from a 2-year Randomized Double-blind Placebo-controlled Trial (CIMESTRA)." Scandinavian Journal of Rheumatology 46, no. 5 (2017): 335. https://doi.org/10.1080/03009742.2016.1209550.

MLA (9th ed.) Citation

Møller-Bisgaard, S., et al. "Effect of a Treat-to-target Strategy Based on Methotrexate and Intra-articular Betamethasone with or Without Additional Cyclosporin on MRI-assessed Synovitis, Osteitis, Tenosynovitis, Bone Erosion, and Joint Space Narrowing in Early Rheumatoid Arthritis: Results from a 2-year Randomized Double-blind Placebo-controlled Trial (CIMESTRA)." Scandinavian Journal of Rheumatology, vol. 46, no. 5, 2017, p. 335, https://doi.org/10.1080/03009742.2016.1209550.